Alan Thomas

Research diagnostic criteria for mild cognitive impairment with Lewy bodies: A systematic review and meta‐analysis

Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias

DNA methylation signatures of Alzheimer’s disease neuropathology in the cortex are primarily driven by variation in non-neuronal cell-types

Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood

Common Variants Near <scp>ZIC1</scp> and <scp>ZIC4</scp> in Autopsy‐Confirmed Multiple System Atrophy

Concomitant neurodegenerative pathologies contribute to the transition from mild cognitive impairment to dementia

Research criteria for the diagnosis of prodromal dementia with Lewy bodies

Recalibrating the epigenetic clock: implications for assessing biological age in the human cortex

Mild Cognitive Impairment: the Manchester consensus

Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management

Neuropsychiatric symptoms in limbic-predominant age-related TDP-43 encephalopathy and Alzheimer’s disease

Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis

Alzheimer’s disease polygenic risk score as a predictor of conversion from mild-cognitive impairment

Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia

CXCR4 involvement in neurodegenerative diseases

PET Tau and Amyloid-β Burden in Mild Alzheimer’s Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers

Non-pharmacological interventions for Lewy body dementia: a systematic review

Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS

Divergent functional connectivity during attentional processing in Lewy body dementia and Alzheimer's disease

Common and distinct patterns of grey-matter volume alteration in major depression and bipolar disorder: evidence from voxel-based meta-analysis

Computational meta‐analysis of statistical parametric maps in major depression

The landscape of pain management in people with dementia living in care homes: a mixed methods study

Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia

Vascular dementia

Neural correlates of attention‐executive dysfunction in lewy body dementia and Alzheimer's disease

Frontotemporal dementia and its subtypes: a genome-wide association study

Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer's disease: association with cognitive impairment

Depression and Synaptic Zinc Regulation in Alzheimer Disease, Dementia with Lewy Bodies, and Parkinson Disease Dementia

A Double-Blind Randomized Placebo-Controlled Withdrawal Trial Comparing Memantine and Antipsychotics for the Long-Term Treatment of Function and Neuropsychiatric Symptoms in People With Alzheimer's Disease (MAIN-AD)

Study of the use of antidepressants for depression in dementia: the HTA-SADD trial – a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine